Last reviewed · How we verify
Silver diamine Fluoride 38%
At a glance
| Generic name | Silver diamine Fluoride 38% |
|---|---|
| Also known as | Advantage Arrest Silver diamine Fluoride 38%, SDF, 38% SDF, E-SDF, Silver diamine fluoride |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Preventing Early Childhood Caries With a Silver Diamine Fluoride Gel (PHASE2)
- Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel (PHASE2)
- Traditional vs. Minimally Invasive Decay Treatments in Primary Molars: An 18-month Split-mouth Randomized Study (NA)
- Building Adaptive School-based Interventions for Caries (PHASE3)
- Effect of Silver Diamine Fluoride on Local Anesthesia in Hypomineralized Molars (NA)
- Effect of Silver Diamine Fluoride and LED Activation on Residual Caries Activity in Class II Cavities (NA)
- Efficacy of Silver Diamine Fluoride Versus Nano-Silver Fluoride in Arresting Active Dentin Caries in Primary Teeth in Young Children (NA)
- Effect Of Silverdiamine Fluoride Gel, Sodium Fluoride With CPP-ACP, APF On Early Childhood Caries - A Randomised Controlled Trial (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Silver diamine Fluoride 38% CI brief — competitive landscape report
- Silver diamine Fluoride 38% updates RSS · CI watch RSS
- Ain Shams University portfolio CI